MEANS AND METHODS OF STIMULATION OF SALIVATION (LITERATURE REVIEW)

  • N.O. Riabushko Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Keywords: xerostomia, stimulation, oral fluid.

Abstract

Currently, a large number of tools and methods are proposed to reduce dryness in the mouth and restore the deficiency of biologically active substances entering the mouth with saliva. Stimulation of salivation can be carried out by both local and systemic means.

The aim of our study was to analyze pharmacological and systemic stimulators of salivation.

Results and discussion

Only three drugs were subjected to a detailed study - bromhexidine, anethole trithione and pilocarpine hydrochloride.

Currently, the development of long-acting (prolonged) drugs is underway, which is a promising solution for long-term treatment of patients with dry mouth.

Local stimulation of salivation is based on irritation of the nerve endings of the oral cavity, which transmit a signal to the salivary glands. Various methods are offered, it is chewing of gums, menthol-containing substances, inert means like paraffin. Chewing gum, mint or citric acid tablets (lollipops) and rinses are recommended in everyday life. Frequent use of these tools is not always effective due to various negative factors. The most important of them is short-term effect, but not the possibility of frequent use. In some patients, drugs such as citric acid can irritate the mucous membranes, especially if its content is increased due to dry mouth. Frequent use of these tools can cause demineralization of teeth.

Many authors recommend so-called "saliva substitutes" or "saliva compensators". Various options of replacement therapy in the form of gels, rinses, sprays, toothpastes, etc. are offered.

To prevent caries during hyposalivation, the authors propose a composition of artificial saliva with a high content of fluoride ions, with the introduction of hydroxyapatite from animal bones.

Researchers offer various methods of stimulation the functional activity of the salivary glands, but the main factor in choosing the appropriate treatment is a favorable assessment of the degree of violation of the patient's salivary glands and the mechanism of violation.

Conclusion. Owing to the review of the literature, we can conclude that the timely diagnosis and treatment of xerostomia is an urgent problem of modern dentistry. Patients need xerostomia correction, because the deficiency of oral fluid significantly affects the condition of teeth, mucous membranes of the mouth and periodontal tissues and the quality of life in general.

Due to the fact that the treatment of xerostomia in some cases is ineffective and impossible, such patients need symptomatic therapy to alleviate the manifestations and consequences of xerostomia. The dental market offers a large number of tools for symptomatic correction of xerostomia. Many literature sources contain conflicting data on their effectiveness.

Therefore, we consider it appropriate to study the comparative evaluation of tools that facilitate the manifestations of xerostomia, as well as to assess the effectiveness of correction of xerostomia depending on the causes of its development.

Downloads

Download data is not yet available.

References

1. Arakelyan MG Klinicheskiy sluchay primeneniya zamenitelya slyunyi KIN HIDRAT u patsientki s boleznyu Shegrena. Evraziyskiy soyuz uchenyih, IV Mezhdunarodnaya nauchno-prakticheskaya konfe¬rentsiya «Sovremennyie kontseptsii nauchnyih issledovaniy», sbornik nauchnyih rabot. 2014. (in Russian).

2. Afanasev VV, Titova ON, Ordashev HA, Ugurchiev YuS. Opyit lecheniya kserostomii s ispolzovaniem spreya Giposaliks. Sovremennaya onkologiya. 2013; 15(2): 62-4. (in Russian).

3. Balyan LN. Kliniko-eksperimentalnoe obosnovanie vyibora sredstv i metodov gigienyi polosti rta bolnyim s kserostomiey [dissertatsiya]. Ekaterinburg: Uralskaya gosudarstvennaya meditsinskaya akademiya; 2002. 22 s. (in Russian).

4. Borovskiy EV, Ivanov VS, Maksimovskiy YuM, Maksimovskaya LN. Terapevticheskaya stomatologiya: uchebnik. Moskva: Meditsina; 2001. 736 s. (in Russian).

5. Vavilova TP, Duhovskaya NE, Ostrovskaya IG. Otsenka gomeostaza polosti rta na fone somaticheskoy patologii. Zdorove, demografiya, ekologiya finno-ugorskih narodov 2017: 42-4.

6. Vavilova TP, Yanushevich OO, Ostrovskaya IG. Slyuna. Analiticheskie vozmozhnosti i perspektivyi. M.: Binom; 2014. 312 s. (in Russian).

7. Gileva OS, Halilaeva EV, Libik TV, Podgornyiy RV, Halyavina IV, Gileva ES. Mnogostupenchataya validatsiya mezhdunarodnogo oprosnika kachestva zhizni «Profil vliyaniya stomatologicheskogo zdorovya» OHIP-49- RU. Uralskiy meditsinskiy zhurnal. 2009; 8: 104-9. (in Russian).

8. Gileva OS. Biohimiya slyunyi, klinika i profilaktika zabolevaniy slizistoy obolochki polosti rta v usloviyah proizvodstvennogo vozdeystviya tabaka [dissertatsiya]. Moskva; 1988. 230 s. (in Russian).

9. Grinin VM Primenenie gelya «OralBalance» u patsientov s kserostomiey. Parodontologiya. 2000; 3: 50-2. (in Russian).

10. Grinin VM, Korsakova TV. Iskusstvennaya slyuna OralBalance i ee rol pri sindrome kserostomii. DentalMarket. 2003; 2: 13-5. (in Russian).

11. Denga OV, Shumilina ES, Makarenko OA. Sravnitelnaya otsenka lechebno-profilakticheskogo deystviya oralnyih mukozoprotektorov «Kaposol» i «Kvertsetin». Vestnik stomatologii. 2013; 1: 29-31. (in Russian).

12. Kuvaeva MN. Klinicheskaya otsenka kollagensoderzhaschego preparata MKG dlya korrektsii luchevo-indutsirovannoy kserostomii i ee oslozhneniy u bolnyih s opuholyami v oblasti golovyi i shei. Studencheskaya meditsinskaya nauka. 2001: 16. (in Russian).

13. Kulyigina VN, Al Mohammad Mohammad Ali. Issledovanyie skorostyi slyunootdeleniya i sostoyaniya kislotno-schelochnogo ravnovesiya v rotovoy polosti u lits molodogo vozrasta s vospalitelnyimi zabolevaniyami tkaney. Zhurnal vushnih I gorlovih hvorob. 2014; 3: 70–3. (in Russian).

14. Leonova LE, Kolomoytsev VF, Pavlova GA, Balueva NM. Sposob lecheniya kserostomii. Patent. Perm. 2005. (in Russian).

15. Mirzakulova UR, Urazalin ZhB, Vansvanov MI, Aktasov NB, Ospanov MZh. Kompleksnoe lechenie giposalivatsii s primeneniem gelya «kserostom». Vestnik KazNMU. 2015; 1: 96-9. (in Russian).

16. Novitskaya NK, Denga OV. Epidemiologicheskie issledovaniya sostoyaniya slyunovyideleniya u naseleniya Ukrainyi, prozhivayuschih v raznih geohimicheskih usloviyah. Ukrainskiy meditsinskiy almanah. 2013; 1: 36–8. (in Russian).

17. Perminova IS, Goydenko VS, Rudenko IV. Opyit primeneniya refleksoterapii pri lechenii sindroma Shegrena. Stomatologiya. 1981; 4: 37-8. (in Russian). (in Russian).

18. Pozharitskaya M.M. Porazhenie organov i tkaney polosti rta pri bolezni Shegrena (patogenez, klinika, diagnostika, lechenie i profilaktika) [dissertatsiya]. Moskva; 1989. 47 s. (in Russian).

19. Romacheva IF, Yudin LA, Kondrateva TS. Sposob lechenie suhosti v polosti rta. Moskva; 1981. 254 s. (in Russian).

20. Tarasenko LM, Neporada KS. Biohimiya organov polosti rta: Poltava; 2007. 59 s. (in Russian).

21. Abraham CM, al-Hashimi I, Haghighat N. Evaluation of the levels of oral Candida in patients with Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 65-8.

22. Costa HJ, Neto OM, Eckley CA. Is there a relationship between the pH and volume of saliva and esophageal pH-metry results Dysphagia. 2005; 20(3): 175-81

23. Eliasson L, Birkhed D, Carlen A. Feeling of dry mouth in relation to whole and minor gland saliva secretion rate. Arch Oral Biol. 2009; 54: 263-7.

24. Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol. 1992; 73: 570-4.

25. Fox PC, Bowman SJ, Segal B, Vivino FB, Murukutla N, Choueiri K, et al. Oral involvement in primary Sjogren syndrome. J Am Dent Assoc. 2008; 139(12): 1592-601.

26. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective masures of salivary gland performance. J Am Dent Assoc 1987; 115: 581-4.

27. Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjogren’s syndrome Crit Rev Oral Biol Med. 1996; 7(2): 144-58.

28. Fox PC. Acquired salivary dysfunction. Drugs and radiation. Ann NY Acad. Sci. 1998; 842: 132-7.

29. Fox PC. Differentiation of Dry Mouth Etiology. Adv Dent Res. 1996; 10: 13-16.

30. Fox PC. Sjogren’s syndrome. Lancet. 2005; 366 (9482): 321-31.

31. Fox PC. Systemic therapy of salivary gland hypofunction. J Dent Res. 1987; 66: 689-92.

32. Fox PC. Xerostomia: recognition and management. Dent Assist. 2008; 77(5): 18-20.

33. Gupta A, Epstein J, Sroussi H. Hyposalivation in Elderly Patients. J Can Dent Assoc. 2006; 72(9): 841-6.

34. Hamada Т, Nakane T, Kimura T, Arisawa K, Yoneda K, Yamamoto T, et al. Treatment of xerostomia with the bile secretionstimulating drug anethole trithione: a clinical trial. Am. J. Med. Sci. 1999; 318(3): 146-51.

35. Jensen SB, Vissink A, Limesand KH, Reyland ME. Salivary gland hypofunction and xerostomia in head and neck radiation patients. JNCI Monographs. 2019; (53): 016.

36. Kholodnyak OV, Dobrovolska MK. Effectiveness of treatment of localized diseases of parodont tissues in young people by the indices of the research of salivation speed and the state of acid base balance of oral cavity. Клінічна стоматологія. 2015; 3-4: 46-52.

37. Miktaniuk SE, Bezrodnyi VV, Fatullaev EI, Marchenko AA, Bychkova EI, Neelov IM. Investigation of complex of lysine dendrimer of 2nd generation with 8 molecules of therapeutic vezugen peptide by computer simulation. Magnetic Resonance and its Applications. 2019: 213-5.

38. Patcharaphol S. Association of hyposalivation with oral function, nutrition, and oral health in visual impaired patient. International Journal of Clinical Preventive Dentistry. 2015; 11(1): 15-20.

39. Torsten WR. Remmerbach. Пониженное слюновыделение. Причины и последствия. Квинтэссенция. 2002;2: 33–42.

40. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. International Journal of Radiation Oncology* Biology* Physics. 2010; 78(4): 983-91.

41. Voskoboynik B, Babu K, Hack JB. Cevimeline (Evoxac®) overdose. Journal of Medical Toxicology. 2011; 7(1): 57-9.

42. Witsell DL, Stinnett S, Chambers MS. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Head & neck. 2012; 34(8): 1136-42.

Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. The Journal of the American Dental Association. 2006; 137(3): 313-21.
Published
2020-09-23
How to Cite
Riabushko, N. (2020). MEANS AND METHODS OF STIMULATION OF SALIVATION (LITERATURE REVIEW). Ukrainian Dental Almanac, (3), 9-14. https://doi.org/10.31718/2409-0255.3.2020.02
Section
THERAPEUTIC DENTISTRY